The 35th CINP World Congress of Neuropsychopharmacology

講演情報

印刷

[CINP2024] Spotlight Session

CINP2024 » Spotlight Session

Spotlight Session 9
Introducing CINP's Global Networking Communities

2024年5月25日(土) 13:00 〜 14:00 Room 5 (G409)

Chair: Joseph Zohar (National Post-Trauma Center, Research Foundation by the Sheba Medical Center, Israel)

Overview:
CINP has recently formed six Global Networking Communities (GNCs) to provide a collaborative and inclusive environment for those with shared subspecialist interest to network with global peers, develop and obtain funding for collective research projects, pursue educational goals, raise awareness of new treatment modalities and build symposia proposals for CINP World Congresses.
Membership of the GNCs is open to all CINP members in good standing, who are eligible to join a maximum of two communities. The first six GNCs to be formed cover the following subspecialist fields:
Difficult to Treat Depression, Digital Intervention, Fast Acting Medications/Psychedelics, Neuromodulation, OCD Spectrum, Precision Psychiatry.
In this session, four of the GNC leaders will introduce their communities and provide an overview of the activities they have planned for the next 12 months.
Audience members will have the opportunity to ask questions and to propose areas of activity for the various communities.

[SS9-2] Digital Intervention GNC

*Kim Q. Do1 (1. Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland)

Prof. Kim Q. Do is Professor for Psychiatric Neuroscience at Lausanne University. Trained as neurobiologist at the Polytechnical Federal School (ETHZ) and Brain Research Institute in Zurich, she is interested in bridging basic neuroscience with problems of clinical psychiatry.
She set up a translational research program aimed at a better understanding of the causes and mechanisms leading to schizophrenia phenotypes in order to develop markers for early diagnosis, new drug targets as well as preventive and therapeutic measures.
Dr. Do’s pioneering and evolving focus on redox dysregulation and oxidative stress in psychosis has a growing influence on schizophrenia research. Her multiple achievements have been acknowledged by membership at the Swiss Academy of Medical Science and numerous awards including the NARSAD Independent Investigator Award from the Brain & Behavior Research Foundation (USA) in 2006, the NARSAD Distinguished Investigator Award in 2010 and, in 2018, the SIRS Outstanding Basic Science Award from the Schizophrenia International Research Society.
Complete list of publications: https://orcid.org/0000-0003-1968-1646
22nd Paul Janssen Lecture 2023, Institute of Psychiatry, Psychology & Neuroscience, King’s College London: www.kcl.ac.uk/ioppn/paul-janssen-lecture

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードを入力して認証してください。

パスワード